Stocks

TMN - Oracle

Oracle stocks hike on upbeat Q4 earnings

Shares of Oracle Corporation rocketed on Tuesday’s pre-market trading after the firm delivered better than expected fiscal fourth-quarter earnings. The American computer software company soared 14.96% or 9.58 points to $73.63 per share. The movement completely reversed the previous downturn of 4.60% or 3.09 points to $64.05 per share. Accordingly, the upsurge added $25.69 billion …

Oracle stocks hike on upbeat Q4 earnings Read More »

TMN - Amazon

Amazon stocks dwindle on bleak Q1 results

Shares of Amazon.com, Inc. edged down in extended trading on Thursday after the company issued disappointing first-quarter results. The world’s biggest online retailer plunged 8.99% or 259.94 points to $2,631.99 per share. It negatively moved from an upswing of 4.65% or 128.59 points to $2,891.93 per share in the regular hours market. Accordingly, the slump …

Amazon stocks dwindle on bleak Q1 results Read More »

TMN - Meta

Meta stocks skyrocket following Q1 earnings beat

Shares of Meta Platforms significantly surged on Wednesday after hours after the company posted earnings that surpassed market estimates. The Facebook parent jumped 18.37% or 32.14 points to $207.09 per share. The stock reversed a decline of 3.32% or 6.00 points to $174.95 per share in the regular trading session. Then, the notable upturn sent …

Meta stocks skyrocket following Q1 earnings beat Read More »

Nektar

Nektar dwindles as it stops trials for cancer drug

Shares of Nektar Therapeutics significantly tumbled on Thursday’s after-hours market after it discontinued clinical trials involving its key cancer drug. The American biopharmaceutical company slumped 17.05% or 1.05 points to $5.11 per share. It trailed a drop of 0.16% or 0.01 points to $6.16 per share in the regular trading session. This downturn dragged $197.59 …

Nektar dwindles as it stops trials for cancer drug Read More »